Found: 28
Select item for more details and to access through your institution.
Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD dataset.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 4, p. 756, doi. 10.1093/mr/road094
- By:
- Publication type:
- Article
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study.
- Published in:
- Rheumatology, 2024, v. 63, n. 5, p. 1341, doi. 10.1093/rheumatology/kead382
- By:
- Publication type:
- Article
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. 657, doi. 10.1093/rheumatology/kead250
- By:
- Publication type:
- Article
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys.
- Published in:
- Rheumatology, 2024, v. 63, n. 1, p. 127, doi. 10.1093/rheumatology/kead180
- By:
- Publication type:
- Article
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys.
- Published in:
- Rheumatology, 2023, v. 62, n. 12, p. 3838, doi. 10.1093/rheumatology/kead144
- By:
- Publication type:
- Article
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys.
- Published in:
- Rheumatology, 2023, v. 62, n. 10, p. 3291, doi. 10.1093/rheumatology/kead057
- By:
- Publication type:
- Article
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study.
- Published in:
- Rheumatology, 2023, v. 62, n. 9, p. e263, doi. 10.1093/rheumatology/kead149
- By:
- Publication type:
- Article
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.
- Published in:
- Rheumatology, 2023, v. 62, n. 7, p. 2453, doi. 10.1093/rheumatology/keac661
- By:
- Publication type:
- Article
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 7, p. 2366, doi. 10.1093/rheumatology/keac624
- By:
- Publication type:
- Article
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey.
- Published in:
- Rheumatology, 2023, v. 62, n. 3, p. 1204, doi. 10.1093/rheumatology/keac441
- By:
- Publication type:
- Article
Abstract 167: COVID-19 vaccine side effects in Type 1 diabetes mellitus patients as compared to healthy controls: Results from the COVAD study.
- Published in:
- Indian Journal of Endocrinology & Metabolism, 2022, v. 26, p. 71, doi. 10.4103/2230-8210.363672
- By:
- Publication type:
- Article
An Observational Study On Pathya Apathya In Ayurveda.
- Published in:
- Journal of Pharmaceutical Negative Results, 2023, v. 14, n. 3, p. 53, doi. 10.47750/pnr.2023.14.03.07
- By:
- Publication type:
- Article
Association of Viharaja and Manasika Hetus (Behavioural and Mental Factors) with Amlapitta (Hyperacidity) amongst Police Professionals in Pune.
- Published in:
- Indian Journal of Public Health Research & Development, 2020, v. 11, n. 6, p. 143
- By:
- Publication type:
- Article
Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 1, p. 131, doi. 10.1111/jdi.14079
- By:
- Publication type:
- Article
Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 5, p. 1, doi. 10.1111/1756-185X.15178
- By:
- Publication type:
- Article
Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 5, p. 1, doi. 10.1111/1756-185X.15161
- By:
- Publication type:
- Article
Flares of autoimmune rheumatic disease following COVID‐19 infection: Observations from the COVAD study.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 1, p. 1, doi. 10.1111/1756-185X.14961
- By:
- Publication type:
- Article
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Assessment of quality and reliability of YouTube videos for patient and physician education on inflammatory myositis.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 5, p. 1339, doi. 10.1007/s10067-023-06522-x
- By:
- Publication type:
- Article
Physicians' perceptions about antineutrophil cytoplasmic antibody-associated vasculitis: an online survey report in the time of the COVID-19 pandemic.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 3, p. 831, doi. 10.1007/s10067-022-06452-0
- By:
- Publication type:
- Article
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study.
- Published in:
- Rheumatology International, 2024, v. 44, n. 9, p. 1725, doi. 10.1007/s00296-024-05654-w
- By:
- Publication type:
- Article
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
- Published in:
- Rheumatology International, 2024, v. 44, n. 1, p. 73, doi. 10.1007/s00296-023-05496-y
- By:
- Publication type:
- Article
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey.
- Published in:
- Rheumatology International, 2024, v. 44, n. 1, p. 89, doi. 10.1007/s00296-023-05433-z
- By:
- Publication type:
- Article
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey.
- Published in:
- Rheumatology International, 2023, v. 43, n. 9, p. 1637, doi. 10.1007/s00296-023-05344-z
- By:
- Publication type:
- Article
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.
- Published in:
- Rheumatology International, 2023, v. 43, n. 9, p. 1651, doi. 10.1007/s00296-023-05345-y
- By:
- Publication type:
- Article
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.
- Published in:
- Rheumatology International, 2023, v. 43, n. 7, p. 1265, doi. 10.1007/s00296-023-05310-9
- By:
- Publication type:
- Article
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
- Published in:
- Rheumatology International, 2023, v. 43, n. 1, p. 47, doi. 10.1007/s00296-022-05229-7
- By:
- Publication type:
- Article
COVAD survey 2 long-term outcomes: unmet need and protocol.
- Published in:
- Rheumatology International, 2022, v. 42, n. 12, p. 2151, doi. 10.1007/s00296-022-05157-6
- By:
- Publication type:
- Article